Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.690
+0.010 (1.41%)
At close: Dec 20, 2024, 4:00 PM
0.669
-0.021 (-3.03%)
After-hours: Dec 20, 2024, 5:18 PM EST
Predictive Oncology Employees
As of December 31, 2023, Predictive Oncology had 35 total employees, including 34 full-time and 1 part-time employees. The number of employees increased by 1 or 2.94% compared to the previous year.
Employees
35
Change (1Y)
1
Growth (1Y)
2.94%
Revenue / Employee
$42,406
Profits / Employee
-$399,147
Market Cap
4.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Evaxion Biotech | 49 |
Sintx Technologies | 43 |
Healthcare Triangle | 31 |
Sonnet BioTherapeutics Holdings | 12 |
Galmed Pharmaceuticals | 8 |
Oragenics | 5 |
POAI News
- 5 weeks ago - Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update - GlobeNewsWire
- 3 months ago - Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 - GlobeNewsWire
- 5 months ago - Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results - GlobeNewsWire
- 6 months ago - Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs) - GlobeNewsWire